Serum proteomic-based analysis for the identification of a potential serological marker for autoimmune hepatitis

Biochemical and Biophysical Research Communications

Volumn 367, Issue 2, 2008, Pages 284-290

  Lu, Feng ^a,b,c   Xia, Qing ^c   Ma, Yuanfang ^b   Yuan, Guogang ^c   Yan, Huiping ^d   Qian, Lu ^c   Hu, Meiru ^c   Wang, Mingli ^b   Lu, Han ^b   Wang, Hongli ^e   Liu, Bingyu ^e   Xue, Yan ^e   Wang, Hongxia ^e   Li, Mingyuan ^a   Shen, Beifen ^c   Guo, Ning ^c  

^a SICHUAN UNIVERSITY   (China)

^b HENAN UNIVERSITY   (China)

^c INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e NATIONAL CENTER OF BIOMEDICAL ANALYSIS   (China)

Author keywords

Autoantibody; Autoimmune hepatitis; Diagnostic marker; Mass spectrometry; Phosphoglycerate mutase isozyme B; Proteomics

Indexed keywords

AUTOANTIGEN; BIOLOGICAL MARKER; COMPLEMENTARY DNA; ISOENZYME; PHOSPHOGLYCERATE MUTASE; RECOMBINANT PROTEIN;

AFFINITY CHROMATOGRAPHY; ARTICLE; AUTOIMMUNE HEPATITIS; BILIARY CIRRHOSIS; CHRONIC DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN CELL; MOLECULAR CLONING; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEOMICS; SEROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD PROTEINS; FEASIBILITY STUDIES; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; MALE; MIDDLE AGED; PHOSPHOGLYCERATE MUTASE; PROTEOME;

ESCHERICHIA COLI; HEPATITIS C VIRUS;

EID: 38349062341     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.12.075     Document Type: Article

References (26)

1. Zolfino T., Heneghan M.A., Norris S., Harrison P.M., Portmann B.C., and McFarlane I.G. Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin. Gut 50 (2002) 713-717
2. Zachou K., Rigopoulou E., and Dalekos G.N. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease. J. Autoimmune Dis. 1 (2004) 2-13
3. Malekzadeh R., Mohamadnejad M., Nasseri-Moghaddam S., Rakhshani N., Tavangar S.M., Sohrabpour A.A., and Tahaghoghi S. Reversibility of cirrhosis in autoimmune hepatitis. Am. J. Med. 117 (2004) 125-129
4. Zeniya M., Watanabe F., Morizane T., Shibata M., Maeyama S., Kage M., Nakanuma Y., and Toda G. Study group of intractable liver diseases for research on a specific disease, health science research grant, ministry of health, labour, and welfare of Japan. Diagnosing clinical subsets of autoimmune liver diseases based on a multivariable model. J. Gastroenterol. 40 (2005) 1148-1154
5. Strassburg C.P., and Manns M.P. Autoantibodies and autoantigens in autoimmune hepatitis. Semin Liver Dis. 22 (2002) 339-351
6. Beland K., Lapierre P., Marceau G., and Alvarez F. Anti-LC1 autoantibodies in patients with chronic hepatitis C virus infection. J. Autoimmun. 22 (2004) 159-166
7. Muratori L., Lenzi M., Ma Y., Cataleta M., Mietli-Vergani G., Vergani D., and Bianchi F.B. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease. Gut 37 (1995) 406-412
8. Vitozzi S., Lapierre P., Djilali-Saiah I., Marceau G., Beland K., and Alvarez F. Anti-soluble liver antigen (SLA) antibodies in chronic HCV infection. Autoimmunity 37 (2004) 217-222
9. Gueguen M., Boniface O., Bernard O., Clerc F., Cartwright T., and Alvarez F. Identification of the main epitope on human cytochrome P450 IID6 recognized by anti-liver kidney microsome antibody. J. Autoimmun. 4 (1991) 607-615
10. m Tc-GSA SPECT in patients with acute hepatic damage. Hepatol. Res. 36 (2006) 130-138
11. Wies I., Brunner S., Henninger J., Herkel J., Kanzler S., Meyer zum Buschenfelde K.H., and Lohse A.W. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet 355 (2000) 1510-1515
12. Ballot E., Bruneel A., Labas V., and Johanet C. Identification of rat targets of anti-soluble liver antigen autoantibodies by serologic proteome analysis. Clin. Chem. 49 (2003) 634-643
13. Huguet S., Labas V., Duclos-Vallee J.C., Bruneel A., Vinh J., Samuel D., Johanet C., and Ballot E. Heterogeneous nuclear ribonuceoprotein A2/B1 identified as an autoantigen in autoimmune hepatitis by proteome analysis. Proteomics 4 (2004) 1341-1345
14. Xia Q., Wang H.X., Wang J., Zhang J.Y., Li A.L., Lv M., Hu M.R., Yu M., Feng J.N., Yang S.C., Zhang X.M., and Shen B.F. Proteomic analysis of interleukin 6-induced differentiation in mouse myeloid leukemia cells. Int. J. Biochem. Cell B. 37 (2005) 1197-1207
15. Gravett M.G., Thomas A., Schneider K.A., Reddy A.P., Dasari S., Jacob T., Lu X., Rodland M., Pereira L., Sadowsky D.W., Roberts Jr. C.T., Novy M.J., and Nagalla S.R. Proteomic analysis of cervical-vaginal fluid: identification of novel biomarkers for detection of intra-amniotic infection. J. Proteome Res. 6 (2007) 89-96
16. Cooper B., Garrett W.M., and Campbell K.B. Shotgun identification of proteins from uredospores of the bean rust Uromyces appendiculatus. Proteomics 6 (2006) 2477-2484
17. Jacob H., Jonathan F., Tony R., Mark D., Melissa H., Tsufit G.G., Efrat M., Samuel Y.C., Michael J.L., and Ofer M. Proteomic analysis of human natural killer cells: insights on new potential NK immune functions. Mol. Immunol. 42 (2005) 425-431
18. Kreunin P., Zhao J., Rosser C., Urquidi V., Lubman D.M., and Goodison S. Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling. J. Proteome Res. 6 (2007) 2631-2639
19. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 7 (1976) 248-254
20. Hamanaka Y., Suehiro Y., Fukui M., Shikichi K., Imai K., and Hinoda Y. Circulating anti-MUC1 IgG antibodies as a favorable prognostic factor for pancreatic cancer. Int. J. Cancer 103 (2003) 97-100
21. Bartons R., and Carreras J. Purification and characterization of phosphoglycerate mutase isozyme from pig heart. Biochim. Biophys. Acta 708 (1982) 167-177
22. Durany N., and Carreras J. Distribution of phosphoglycerate mutase isozymes in rat, rabbit and human tissues. Comp. Biochem. Physiol. B. Biochem. Mol. Biol. 114 (1996) 217-223
23. Castella-Escola J., Ojicius D.M., LeBoulch P., Joulin V., Blouquit Y., Garel M.C., Valentin C., Rose R., Climent-Romeo F., and Cohen-Solal M. Isolation and characterization of the gene encoding the muscle-specific isozyme of human phosphoglycerate mutase. Gene 91 (1990) 225-232
24. Durany N., Joseph J., Cruz-Sanchez F.F., and Carreras J. Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase and creatine kinase activity and isozymes in human brain tumours. Br. J. Cancer 76 (1997) 1139-1149
25. Takahashi Y., Takahashi S., Yoshimi T., and Miura T. Hypoxia-induces expression of phosphoglycerate mutase B in fibroblasts. Eur. J. Biochem. 254 (1998) 497-504
26. Hayashi T., and Matuo Y. A new stroke marker as detected by serum phosphoglycerate mutase B-type isozyme. Biochem. Bioph. Res. Co. 287 (2001) 843-845